Skip to main content

Want a detailed portfolio tracker?

Titan Pharmaceuticals Inc (de) (TTNP) P/E

Titan Pharmaceuticals Inc (de) (TTNP) P/E from Jun 30, 2025 to Oct 1, 2025. The TTM Titan Pharmaceuticals Inc (de) (TTNP) P/E is -7.12. You can export chart.

P/E

Annual P/E change of Titan Pharmaceuticals Inc (de) (TTNP)

YearP/EChange
2025-7.12N/A

Comparison Titan Pharmaceuticals Inc (de) (TTNP) P/E with competitors

Titan Pharmaceuticals Inc (de) (TTNP) P/E is -7.12.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.05%
FGENFibroGen Inc0.24-103.37%
CHRSCoherus Biosciences Inc0.85-111.92%
FBIOFortress Biotech Inc0.95-113.34%
ORMPOramed Pharmaceuticals Inc1.50-121.12%
AGENAgenus Inc3.01-142.30%
INVAInnoviva Inc3.15-144.32%
VXRTVaxart Inc3.55-149.89%
CRMDCorMedix Inc3.63-150.99%
CVACCureVac N.V.4.45-162.48%
GLPGGalapagos NV4.86-168.28%
SRPTSarepta Therapeutics Inc4.88-168.61%
ABEOAbeona Therapeutics Inc5.39-175.71%
ABUSArbutus Biopharma Corp5.60-178.64%
ZVRAZevra Therapeutics Inc5.89-182.74%
SPROSpero Therapeutics Inc6.23-187.53%
CGENCompugen Ltd6.31-188.73%
RIGLRigel Pharmaceuticals6.87-196.58%
SLXNSilexion Therapeutics Corp7.30-202.53%
OMEROmeros Corporation9.26-230.12%
AUPHAurinia Pharmaceuticals Inc9.58-234.70%
PLXProtalix BioTherapeutics Inc10.89-253.06%
ACADAcadia Pharmaceuticals Inc11.73-264.83%
TBPHTheravance Biopharma Inc12.26-272.33%
ADMAAdma Biologics Inc12.42-274.52%
HRMYHarmony Biosciences Holdings Inc13.82-294.22%
SABSSAB Biotherapeutics Inc14.14-298.66%
NAGENiagen Bioscience Inc14.82-308.25%
INCYIncyte Corp15.82-322.36%
REGNRegeneron Pharmaceuticals Inc15.86-322.84%
PBYIPuma Biotechnology Inc17.32-343.35%
CPRXCatalyst Pharmaceuticals Inc17.44-345.08%
EXELExelixis Inc17.54-346.47%
TGTXTG Therapeutics Inc18.97-366.54%
MDXGMimedx Group Inc20.55-388.83%
XOMAXOMA Royalty Corp22.87-421.48%
ARGXArgen X SE24.30-441.48%
CTMXCytomX Therapeutics Inc24.82-448.83%
XOMAOXOMA Royalty Corp25.34-456.19%
HALOHalozyme Therapeutics Inc25.62-460.11%
XOMAPXOMA Royalty Corp25.67-460.76%
VRTXVertex Pharmaceuticals Inc27.99-493.43%
RPRXRoyalty Pharma plc - Class A28.69-503.17%
SLNOSoleno Therapeutics Inc29.02-507.78%
ASNDAscendis Pharma A/S30.09-522.82%
LGNDLigand Pharmaceuticals Inc - Class B37.91-632.81%
APLSApellis Pharmaceuticals Inc39.02-648.40%
BMRNBiomarin Pharmaceutical Inc42.21-693.24%
KRYSKrystal Biotech Inc45.34-737.25%
ONCBeiGene Ltd69.54-1077.31%
PHARPharming Group N.V.75.03-1154.40%
TECHBio-Techne Corp101.96-1532.91%
VCELVericel Corp109.92-1644.82%
ALNYAlnylam Pharmaceuticals Inc117.96-1757.86%
GMABGenmab140.29-2071.63%
TLXTelix Pharmaceuticals Ltd162.15-2378.87%
CORTCorcept Therapeutics Inc212.86-3091.47%